Pharmaceutial & Healthcare

25-mar-2019 Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert). Pharmacokinetically, it resembles basal insulin secretion of non-diabetic pancreatic beta cells. Sometimes, in type 2 diabetes and in combination with a short acting sulfonylurea (drugs which stimulate the pancreas to make more insulin), it can offer moderate control of serum glucose levels. In the absence of endogenous insulin-type 1 diabetes, depleted type 2 (in some cases) or latent autoimmune diabetes of adults in late stage-insulin glargine needs the support of fast acting insulin taken with food to reduce the effect of prandially derived glucose. This report provides detailed analysis of w...

25-mar-2019 The Viaminate Market 2017 Report offers detailed analysis of the Viaminate market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Viaminate market . It further lays out an analysis of the factors influencing the supply/demand for Viaminate, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Viaminate market...

25-mar-2019  It is anticipated to expand at a CAGR of 6.6% during the forecast period. Increasing cost of drug development is expected to drive the growth. Drug maker and sponsor companies are under pressure to replace the revenue loss caused by generics, increasing patent expirations, number of partnerships to identify biologics, and growing R&D costs, which has made drug development more expensive and complex. Regulatory framework for drug discovery and drug development is complex in various countries. Thus, an increasing need for expertise in different areas of drug development is driving the demand for outsourcing services. Drug companies are not only outsourcing production of medicines, but also clinical trials. With increasing privatization of clinical trials, there has been an increase in outsourcing of manufacturing processes to developing regions such as India, China, and Latin American countries. China and India are projected to witness tremendous growth in near ...

25-mar-2019 Hospital Stretchers Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Hospital Stretchers basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) Basic Information; 2.) Asia Hospital Stretchers M...

25-mar-2019 Oncology Surgery Microscope Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Oncology Surgery Microscope basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with:  1.) basic information; 2.) the Asia ...

18-mar-2019 In this report, the global Ketoprofen Patches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ketoprofen Patches for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Ketoprofen Patches market competition by top manufacturers/players, with Ketoprofen Patches sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including • GlaxoSmithKline • Endo International • Hisamitsu Pharmaceutical • Pfizer • Mylan • ALLERGAN On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into  B...

18-mar-2019 In this report, the global Hyperthermia Treatment for Cancer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hyperthermia Treatment for Cancer for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Hyperthermia Treatment for Cancer market competition by top manufacturers/players, with Hyperthermia Treatment for Cancer sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including • Andromedic Sri • Celsius42 GmbH • Huahang • Pyrexar Medical • Perseon Medical • Omron Corporation • Sjn AG Yamamoto Vinita On the basis of product, this report displays the product...

18-mar-2019 In this report, the United States Asthma Medication market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Asthma Medication in these regions, from 2012 to 2022 (forecast). United States Asthma Medication market competition by top manufacturers/players, with Asthma Medication sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Dulera QVAR Glaxosmithkline plc MAP Pharmaceuticals?Inc Merck & Co. Inc AstraZeneca plc Roche Holdings Ltd Genentech Inc Sepracor, Inc Schering-Plough Corp Sanofi-Aventis Theravance Inc On the basis of product, this report displays the ...

18-mar-2019 In this report, the United States Active Pharmaceutical Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Active Pharmaceutical Ingredient in these regions, from 2012 to 2022 (forecast). United States Active Pharmaceutical Ingredient market competition by top manufacturers/players, with Active Pharmaceutical Ingredient sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Teva Novartis Pfizer Johnson & Johnson Mylan North China Pharmaceutical Group Dr. Reddy's Laboratories Roche Aurobindo pharma Sun Pharmaceutical Industries Boehringer Ingelheim ...

18-mar-2019 In this report, the United States Pharmaceuticals Packaging market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Pharmaceuticals Packaging in these regions, from 2012 to 2022 (forecast). United States Pharmaceuticals Packaging market competition by top manufacturers/players, with Pharmaceuticals Packaging sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Gerresheimer Amcor ACG Gerresheimer Schott DuPont? West-P Bilcare Nipro AptarGroup Svam Packaging Bemis Healthcare Datwyler On the basis of product, this report displays the sales volume, revenue, product pr...

18-mar-2019 In this report, the United States Iron Deficiency Anemia Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Iron Deficiency Anemia Drug in these regions, from 2012 to 2022 (forecast). United States Iron Deficiency Anemia Drug market competition by top manufacturers/players, with Iron Deficiency Anemia Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including GlaxoSmithKline Bluebird bio GlycoMimetics Mast Therapeutics Bayer AG Eli Lilly Acceleron Pharma Regen biopharma On the basis of product, this report displays the production, revenue, price, market share...

18-mar-2019 In this report, the United States Hysteroscopy and Accessories market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Hysteroscopy and Accessories in these regions, from 2012 to 2022 (forecast). United States Hysteroscopy and Accessories market competition by top manufacturers/players, with Hysteroscopy and Accessories sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including OLYMPUS GIMMI GmbH Ackermann Instrumente Rudolf Medical Stryker Endoscopy Richard Wolf SOPRO-COMEG GmbH Smith & Nephew STEMA Medizintechnik Hologic Orimsys GmbH XION GmbH MGB Karl Storz On t...

18-mar-2019 The Adefovir Market 2017 Report offers detailed analysis of the Adefovir market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Adefovir market . It further lays out an analysis of the factors influencing the supply/demand for Adefovir, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Adefovir market dur...

18-mar-2019 The Pidotimod Market 2017 Report offers detailed analysis of the Pidotimod market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Pidotimod market. It further lays out an analysis of the factors influencing the supply/demand for Pidotimod , and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Pidotimod market...

18-mar-2019 The Cloxacillin Market 2017 Report offers detailed analysis of the Cloxacillin market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Cloxacillin market. It further lays out an analysis of the factors influencing the supply/demand for Cloxacillin, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Cloxaci...

15-mar-2019 The Dantrolene Market 2017 Report offers detailed analysis of the Dantrolene market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Dantrolene market. It further lays out an analysis of the factors influencing the supply/demand for Dantrolene, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Dantrolene m...

15-mar-2019 The Bufexamac Market 2017 Report offers detailed analysis of the Bufexamac market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Bufexamac market. It further lays out an analysis of the factors influencing the supply/demand for Bufexamac, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Bufexamac market...

15-mar-2019 The Sertraline Market 2017 Report offers detailed analysis of the Sertraline market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Sertraline market. It further lays out an analysis of the factors influencing the supply/demand for Sertraline, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Sertraline ...

15-mar-2019 The Paroxetine Market 2017 Report offers detailed analysis of the Paroxetine market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Paroxetine market. It further lays out an analysis of the factors influencing the supply/demand for Paroxetine , and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Paroxetine ...

15-mar-2019 In this report, the global Verapamil Hydrochloride market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Verapamil Hydrochloride in these regions, from 2012 to 2022 (forecast), covering • North America • Europe • China • Japan • Southeast Asia • India Global Verapamil Hydrochloride market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including • Bharat Pharmaceuticals • Titan Pharma (India) Pvt Ltd • Vpl Chemicals Pvt Ltd • Wuhan Fortuna Chemical Co., Ltd • Abbott • Boc Sciences • Chemische Fabrik Weyl Gmbh • Chinoin Pharmaceutcial And Chemical Works Co Ltd • Divis Laboratories Ltd • Drug'on Pharma Swit...

15-mar-2019 In this report, the global Topical Corticosteroids market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Topical Corticosteroids for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Topical Corticosteroids market competition by top manufacturers/players, with Topical Corticosteroids sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including AstraZeneca plc GlaxoSmithKline plc Merck & Co., Inc. Pfizer Inc. Sandoz AG (Novartis AG) Sanofi S.A. Actimis Pharmaceuticals Valeant Pharmaceuticals Almirall, S.A Zylera Pharmaceuticals On the basis of product, this report displays ...

15-mar-2019 In this report, the global High Blood Pressure Drugs (Hypertension) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of High Blood Pressure Drugs (Hypertension) for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global High Blood Pressure Drugs (Hypertension) market competition by top manufacturers/players, with High Blood Pressure Drugs (Hypertension) sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Eli Lilly Pfizer Bayer Symplmed Novartis Merck Sanofi Boryung Reata Pharmaceuticals Lung Biotechnology Yuhan Takeda Alvogen On the basis of product, this report displ...

15-mar-2019 In this report, the global Fluconazole market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Fluconazole for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Fluconazole market competition by top manufacturers/players, with Fluconazole sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer Bayer Teva Pharmaceuticals Apotex Inc. GREENSTONE LLC Citron Pharma Hexal AG BM Pharmacy Inc. Lunan Pharmaceutical Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-fluconazole-sales-market-report-2017/request-sample On the basis of produc...

14-mar-2019 In this report, the global High Blood Pressure Drugs (Hypertension) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of High Blood Pressure Drugs (Hypertension) for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global High Blood Pressure Drugs (Hypertension) market competition by top manufacturers/players, with High Blood Pressure Drugs (Hypertension) sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Eli Lilly Pfizer Bayer Symplmed Novartis Merck Sanofi Boryung Reata Pharmaceuticals Lung Biotechnology Yuhan On the basis of product, this report displays the productio...

14-mar-2019 In this report, the global High Blood Pressure Drugs (Hypertension) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of High Blood Pressure Drugs (Hypertension) for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global High Blood Pressure Drugs (Hypertension) market competition by top manufacturers/players, with High Blood Pressure Drugs (Hypertension) sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Eli Lilly Pfizer Bayer Symplmed Novartis Merck Sanofi Boryung Reata Pharmaceuticals Lung Biotechnology Yuhan On the basis of product, this report displays the productio...

14-mar-2019 In this report, the global Fluconazole market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Fluconazole for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Fluconazole market competition by top manufacturers/players, with Fluconazole sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer Bayer Teva Pharmaceuticals Apotex Inc. GREENSTONE LLC Citron Pharma Hexal AG BM Pharmacy Inc. Lunan Pharmaceutical On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Tablet Capsule Injecti...

14-mar-2019 In this report, the global Diabetes Care Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Care Products for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Diabetes Care Products market competition by top manufacturers/players, with Diabetes Care Products sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including BD Bayer Abbott B. Braun Medtronic Tandem Diabetes Care Insulet Corporation Roche J&J ARKRAY Inc Ypsomed Sannuo Sanofi On the basis of product, this report displays the production, revenue, price, market share and growth rate of each ...

14-mar-2019 In this report, the global Antibiotics and Antimycotics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Antibiotics and Antimycotics for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Antibiotics and Antimycotics market competition by top manufacturers/players, with Antibiotics and Antimycotics sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer Novartis Sanofi Roche Merck GSK Johnson & Johnson AstraZeneca Eli Lilly AbbVie Bayer On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, ...